NYSE American · Medical Instruments & Supplies · USD
Milestone Scientific Inc. (MLSS) Stock Analysis
Milestone Scientific Inc. (MLSS) is a Medical Instruments & Supplies stock listed on NYSE American and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MLSS Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.45
- Previous Close
- $0.47
- Day's Range
- 0.45–0.47
- 52-Week Range
- 0.22–0.64
- Volume
- 37.80K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.07
Valuation
- Market Cap
- $41.64M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 4.42
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.05
Financials (FY)
- Revenue (FY)
- $8.97M+3.99%
- Net Income (FY)
- −$5.72M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −43.98%
- Shares Outstanding
- 88.74M
- 1-Year Return
- −24.19%
Dividend and dates
- Earnings Date
- November 12, 2026
- Avg Volume
- 170.43K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
MLSS Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +74.07% |
| 2025 | −71.88% |
| 2024 | +39.13% |
| 2023 | +43.75% |
| 2022 | −76.70% |
| 2021 | −2.83% |
| 2020 | +52.52% |
| 2019 | +321.21% |
| 2018 | −72.03% |
| 2017 | −15.71% |
| 2016 (partial year) | −45.31% |
As of September 4, 2026.
MLSS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $8.97M | −$5.72M | −63.8% |
| 2024 | $8.63M | −$4.71M | −54.6% |
| 2023 | $9.83M | −$6.93M | −70.5% |
| 2022 | $8.81M | −$8.71M | −98.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $8.97M | $6.41M | −$5.70M | −$5.72M | −63.8% |
| 2024 | $8.63M | $6.43M | −$6.76M | −$4.71M | −54.6% |
| 2023 | $9.83M | $6.79M | −$7.11M | −$6.93M | −70.5% |
| 2022 | $8.81M | $4.90M | −$8.83M | −$8.71M | −98.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MLSS Valuation vs Medical Instruments & Supplies Median
Median of 55 stocks| Metric | MLSS | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/S ratio | 4.42 | 3.17 | 39% above |
| Profit margin | −43.98% | 0.85% | 44.8 pts below |
Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet
BenzingaMilestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
SeekingAlphaConference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
BenzingaConference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est
BenzingaTranscript: Milestone Scientific Q2 2026 Earnings Conference Call
BenzingaMilestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M Estimate
Benzinga
All 7 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$131.38B
BDXBecton, Dickinson and Company
$50.32B
MDLNMedline Inc.
$49.23B
ALCAlcon Inc.
$34.08B
RMDResMed Inc.
$32.94B
WSTWest Pharmaceutical Services, Inc.
$23.93B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B





